Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy

Acta Ophthalmologica

Volumn 90, Issue 8, 2012, Pages 750-755

  Tilma, Kathrine Kleis ^a   Bek, Toke ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

diabetic retinopathy; diameter response; diclofenac; latanoprost; metabolic autoregulation; pressure autoregulation; vasodilatation

Indexed keywords

DICLOFENAC; LATANOPROST; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTERIOLE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC PATIENT; DIABETIC RETINOPATHY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISOMETRIC EXERCISE; MALE; OPHTHALMOLOGY; OPTOMETRY; PATHOGENESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD VESSEL;

ADMINISTRATION, TOPICAL; ADULT; ANTIHYPERTENSIVE AGENTS; ARTERIOLES; BLOOD GLUCOSE; BLOOD PRESSURE; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; HEMOSTASIS; HUMANS; INTRAOCULAR PRESSURE; MALE; PROSTAGLANDINS F, SYNTHETIC; RETINAL ARTERY; VASODILATION; VISUAL ACUITY;

EID: 84870547618     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02185.x     Document Type: Article

References (37)

1. Arend O, Harris A, Wolter P, &, Remky A, (2003): Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients. Acta Ophthalmol Scand 81: 474-479.
2. Baba T, Nagayama M, Ohtsuki H, Hirooka K, &, Shiraga F, (2008): Macular edema associated with latanoprost use in a patient with idiopathic juxtafoveal retinal telangiectasis. Jpn J Ophthalmol 52: 68-70.
3. Bek T, Hajari J, &, Jeppesen P, (2008): Interaction between flicker-induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetes. Graefes Arch Clin Exp Ophthalmol 246: 763-769.
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, & Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (2005): The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539-1549.
5. Costa VP, Harris A, &, Stefansson E, (2003): The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res 22: 769-805.
6. Erkin EF, Tarhan S, Kayikcioglu OR, Deveci H, Guler C, &, Goktan C, (2004): Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma. Eur J Ophthalmol 14: 211-219.
7. Garhofer G, Bek T, &, Boehm AG, (2010): Use of the retinal vessel analyzer in ocular blood flow research. Acta Ophthalmol 88: 717-722.
8. Garner A, (1993): Histopathology of diabetic retinopathy in man. Eye (Lond) 7 (Pt 2): 250-253.
9. Georgopoulos GT, Diestelhorst M, Fisher R, Ruokonen P, &, Krieglstein GK, (2002): The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta Ophthalmol Scand 80: 54-58.
10. Geyer O, Man O, Weintraub M, &, Silver DM, (2001): Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol 131: 198-202.
11. Gherghel D, Hosking SL, Cunliffe IA, &, Armstrong RA, (2008): First-line therapy with latanoprost 0.005% results in improved ocular circulation in newly diagnosed primary open-angle glaucoma patients: a prospective, 6-month, open-label study. Eye (Lond) 22: 363-369.
12. Goa KL, &, Chrisp P, (1992): Ocular diclofenac. A review of its pharmacology and clinical use in cataract surgery, and potential in other inflammatory ocular conditions. Drugs Aging 2: 473-486.
13. Harris A, Migliardi R, Rechtman E, Cole CN, Yee AB, &, Garzozi HJ, (2003): Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients. Eur J Ophthalmol 13: 24-31.
14. Harris A, Garzozi HJ, McCranor L, Rechtman E, Yung CW, &, Siesky B, (2009): The effect of latanoprost on ocular blood flow. Int Ophthalmol 29: 19-26.
15. Holmgaard K, &, Bek T, (2010): Adenosine-tri-phosphate (ATP) induced relaxation of porcine retinal arterioles in vitro depends on prostaglandin E synthesized in the perivascular retinal tissue. Invest Ophthalmol Vis Sci 51: 5168-5175.
16. Holmgaard K, Aalkjaer C, Lambert JD, Hessellund A, &, Bek T, (2008): The relaxing effect of perivascular tissue on porcine retinal arterioles in vitro is mimicked by N-methyl-D-aspartate and is blocked by prostaglandin synthesis inhibition. Acta Ophthalmol 86: 26-33.
17. Ishibashi S, Hirose N, Tawara A, &, Kubota T, (2006): Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma. J Glaucoma 15: 354-357.
18. Jeppesen P, Gregersen PA, &, Bek T, (2004): The age-dependent decrease in the myogenic response of retinal arterioles as studied with the retinal vessel analyzer. Graefes Arch Clin Exp Ophthalmol 242: 914-919.
19. Kern TS, Miller CM, Du Y, &, Zheng L, (2007): Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56: 373-379.
20. Kohner EM, Patel V, &, Rassam SM, (1995): Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44: 603-607.
21. Koz OG, Ozsoy A, Yarangumeli A, Kose SK, &, Kural G, (2007): Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial. Acta Ophthalmol Scand 85: 838-843.
22. Kristinsson JK, Gottfredsdottir MS, &, Stefansson E, (1997a): Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 81: 274-278.
23. Liu CJ, Ko YC, Cheng CY, Chiu AW, Chou JC, Hsu WM, &, Liu JH, (2002): Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients. Ophthalmology 109: 2241-2247.
24. Miyake K, &, Ibaraki N, (2002): Prostaglandins and cystoid macular edema. Surv Ophthalmol 47 (Suppl 1): S203-S218.
25. Nicolela MT, Buckley AR, Walman BE, &, Drance SM, (1996): A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels. Am J Ophthalmol 122: 784-789.
26. Ozdemir H, Karacorlu M, &, Karacorlu SA, (2008): Serous detachment of macula in cystoid macular edema associated with latanoprost. Eur J Ophthalmol 18: 1014-1016.
27. Ozkan B, Karabas VL, Yuksel N, &, Caglar Y, (2008): Serous retinal detachment in the macula related to latanoprost use. Int Ophthalmol 28: 363-365.
28. Parys-Van Ginderdeuren R, Malcolm D, Varma DR, Aranda JV, &, Chemtob S, (1992): Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs. Invest Ophthalmol Vis Sci 33: 3378-3384.
29. Polak K, Schmetterer L, &, Riva CE, (2002): Influence of flicker frequency on flicker-induced changes of retinal vessel diameter. Invest Ophthalmol Vis Sci 43: 2721-2726.
30. Seong GJ, Lee HK, &, Hong YJ, (1999): Effects of 0.005% latanoprost on optic nerve head and peripapillary retinal blood flow. Ophthalmologica 213: 355-359.
31. Shimura M, Nakazawa T, Yasuda K, &, Nishida K, (2007): Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. J Ocul Pharmacol Ther 23: 284-291.
32. Soheilian M, Karimi S, Ramezani A, &, Peyman GA, (2010): Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. Retina 30: 509-515.
33. Tamaki Y, Nagahara M, Araie M, Tomita K, Sandoh S, &, Tomidokoro A, (2001): Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther 17: 403-411.
34. Vilser W, Nagel E, &, Lanzl I, (2002): Retinal vessel analysis-new possibilities. Biomed Tech (Berl) 47 (Suppl 1 Pt 2): 682-685.
35. Warren KA, Bahrani H, &, Fox JE, (2010a): NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. Retina 30: 260-266.
36. Weigert G, Berisha F, Resch H, Karl K, Schmetterer L, &, Garhofer G, (2008): Effect of unspecific inhibition of cyclooxygenase by indomethacin on retinal and choroidal blood flow. Invest Ophthalmol Vis Sci 49: 1065-1070.
37. Zeitz O, Matthiessen ET, Reuss J, Wiermann A, Wagenfeld L, Galambos P, Richard G, &, Klemm M, (2005): Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428]. BMC Ophthalmol 5: 6.